The E1A N terminus (aa 1-29) of the highly oncogenic adenovirus type 12 harbours a trans-activation function not detectable in the non-oncogenic serotype 2

Journal of General Virology

Volumn 78, Issue 2, 1997, Pages 413-421

  Lipinski, Kai S ^a   Kröner Lux, Gabriele ^a,b   Esche, Helmut ^a   Brockmann, Dieter ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ADENOVIRUS 12; AMINO TERMINAL SEQUENCE; ARTICLE; DELETION MUTANT; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REPRESSOR GENE; SEROTYPE; TRANSACTIVATION; VIRUS ONCOGENE;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 12;

EID: 0031020239     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-2-413     Document Type: Article

References (49)

1. Arany, Z., Newsome, D., Oldread, E., Livingston, D. M. & Eckner, R. (1995). A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374, 81-84.
2. Berk, A. J., Lee, F., Harrison, T., Williams, J. & Sharp, P. A. (1979). Preearly adenovirus 5 product regulates synthesis of early viral messenger RNAs. Cell 17, 935-944.
3. Bondesson, M., Mannervik, M., Akusjärvi, G. & Svensson, C. (1994). An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter. Nucleic Acids Research 22, 3053-3060.
4. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248-254.
5. Brockmann, D. & Esche, H. (1995). Regulation of viral and cellular gene expression by E1A proteins encoded by the oncogenic adenovirus type 12. Current Topics in Microbiology and Immunology 199/III, 82-112.
6. Brockmann, D., Tries, B. & Esche, H. (1990). Isolation and characterization of novel adenovirus type 12 E1A mRNAs by cDNA PCR technique. Virology 179, 585-590.
7. Byers Kraus, V., Inostroza, J. A., Yeung, K., Reinberg, O. & Nevins, J. R. (1994). Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by adenovirus E1A. Proceedings of the National Academy of Sciences, USA 91, 6279-6282.
8. Byrd, P. J., Grand, R. J. & Gallimore, P. M. (1988). Differential transformation of primary human embryo retinal cells by adenovirus E1 regions and combinations of E1A+ras. Oncogens 2, 477-484.
9. Chen, J.-L., Attardi, L. D., Verrijzer, C. P., Yokomori, K. & Tjian, R. (1994). Assembly of recombinant TFIID reveals differential co-activator requirements for distinct transcriptional activators. Cell 79, 93-105.
10. Chevray, P. M. & Nathans, D. (1992). Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun. Proceedings of the National Academy of Sciences, USA 89, 5789-5793.
11. Egan, C., Jelsma, T. N., Howe, J. A., Bayley, S. T., Ferguson, B. & Branton, P. E. (1988). Mapping of cellular protein-binding sites on the products of early region 1A of human adenovirus type 5. Molecular and Cellular Biology 8, 3955-3959.
12. Feigner, P. & Ringold, G. (1989). Cationic liposome-mediated transfection. Nature 337, 387-388.
13. Ferguson, B., Krippl, B., Andrisani, O., Jones, N., Westphal, H. & Rosenberg, M. (1985). E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA. Molecular and Cellular Biology 5, 2653-2661.
14. Gedrich, R. W., Bayley, S. T. & Engel, D. A. (1992). Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation. Journal of Virology 66, 5849-5859.
15. Gorman, C., Merlino, G., Willingham, M., Pastan, I. & Howard, B. (1982). The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eucaryotic cells by DNA-mediated transfection. Proceedings of the National Academy of Sciences, USA 79, 6777-6781.
16. Harlow, E. & Lane, D. (1988). Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
17. Harlow, E., Whyte, P., Franza, B. R., Jr & Schley, C. (1986). Association of adenovirus early-region 1A proteins with cellular polypeptides. Molecular and Cellular Biology 6, 1579-1589.
18. Houweling, A., van den Elsen, P. J. & van der Eb, A. J. (1980). Partial transformation of primary rat cells by the leftmost 4·5% fragment of adenovirus 5 DNA. Virology 105, 537-550.
19. Inostroza, J. A., Mermelstein, F. H., Ha, I., Lane, W. S. & Reinberg, D. (1992). Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription. Cell 70, 477-489.
20. Jelinek, T., Pereira, D. S. & Graham, F. L. (1994). Tumorigenicity of adenovirus-transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A. Journal of Virology 68, 888-896.
21. Jochemsen, H., Daniëls, G. S. G., Hertoghs, J. J. L., Schrier, P. I., van den Elsen, P. J. & van der Eb, A. J. (1982). Identification of adenovirus-type 12 gene products involved in transformation and oncogenesis. Virology 122, 15-28.
22. Jones, N. & Shenk, T. (1979). An adenovirus type 5 early gene function regulates expression of other early genes. Proceedings of the National Academy of Sciences, USA 76, 3665-3669.
23. Lee, W. S., Kao, C. C., Bryant, G. O., Liu, X. & Berk, A. J. (1991). Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell 67, 365-376.
24. Lewis, B. A., Tullis, G., Seto, E., Horikoshi, N., Weinmann, R. & Shenk, T. (1995). Adenovirus E1A proteins interact with the cellular YY1 transcription factor. Journal of Virology 69, 1628-1636.
25. Lillie, J. W. & Green, M. R. (1989). Transcription activation by the adenovirus E1A protein. Nature 338, 39-44.
26. Liu, F. & Green, M. R. (1990). A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1A protein. Cell 61, 1217-1224.
27. Liu, F. & Green, M. R. (1994). Promoter targeting by adenovirus E1A through interaction with different cellular DNA-binding domains. Nature 368, 520-525.
28. Lundblad, J. R., Kwok, R. P. S., Laurance, M. E., Harter, M. L. & Goodman, R. H. (1995). Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374, 85-88.
29. Ma, J. & Ptashne, M. (1987). A new class of yeast transcriptional activators. Cell 51, 113-119.
30. Miller, M. E., Engel, D. A. & Smith, M. M. (1995). Cyclic AMP signaling is required for function of the N-terminal and CR1 domains of adenovirus E1A in Saccharomyces cerevisiae. Oncogens 11, 1623-1630.
31. Moran, E. (1993). DNA tumor virus transforming proteins and the cell cycle. Current Opinion in Genetics & Development 3, 63-70.
32. Murphy, M., Opalka, B., Sajaczkowski, R. & Schulte-Holthausen, H. (1987). Definition of a region required for transformation in E1A of adenovirus 12. Virology 159, 49-56.
33. Nevins, J. R. (1981). Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell 26, 213-220.
34. Pereira, D. S., Rosenthal, K. L. & Graham, F. L. (1995). Identification of adenovirus E1A regions which affect MHC class I expression and susceptibility to cytotoxic T lymphocytes. Virology 211, 268-277.
35. Rochette-Egly, C., Fromental, C. & Chambon, P. (1990). General repression of enhanson activity by the adenovirus-2 E1A proteins. Genes & Development 4, 137-150.
36. Ruley, H. E. (1983). Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304, 602-606.
37. Shenk, T. & Flint, J. (1991). Transcriptional and transforming activities of the adenovirus E1A proteins. Advances in Cancer Research 57, 47-83.
38. Simon, M. C., Fisch, T. M., Benecke, B. J., Nevins, J. R. & Heintz, N. (1988). Identification of multiple, functionally distinct TATA elements, one of which is the target in the hsp70 promoter for E1A regulation. Cell 52, 723-729.
39. Swaminathan, S. & Thimmapaya, B. (1995). Regulation of adenovirus E2 transcription unit. Current Topics in Microbiology and Immunology 199/III, 177-194.
40. Tjian, R. & Maniatis, T. (1994). Transcriptional activaton: a complex puzzle with few pieces. Cell 77, 5-8.
41. Van Ormondt, H. & Galibert, F. (1984). Nucleotide sequences of adenovirus DNAs. Current Topics in Microbiology and Immunology 110, 73-143.
42. Wang, H.-G. H., Rikitake, Y., Carter, M. C., Yaciuk, P., Abraham, S. E., Zerler, B. & Moran, E. (1993a). Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. Journal of Virology 67, 476-488.
43. Wang, H.-G. H., Yaciuk, P., Ricciardi, R. P., Green, M., Yokoyama, K. & Moran, E. (1993b). The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retino-blastoma protein but not p300. Journal of Virology 67, 4804-4813.
44. Weinberg, R. A. (1996). E2F and cell proliferation: a world turned upside down. Cell 85, 457-459.
45. Williams, J., Williams, M., Liu, C. & Telling, G. (1995). Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses. Current Topics in Microbiology and Immunology 199/III, 149-175.
46. Wu, L., Rosser, D. S. E., Schmidt, M. C. & Berk, A. (1987). A TATA box implicated in E1A transcriptional activation of a simple adenovirus 2 promoter. Nature 326, 512-515.
47. Yee, S.-P. & Branton, P. E. (1985). Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. Virology 147, 142-153.
48. Zerler, B., Moran, B., Maruyama, K., Moomaw, J., Grodzicker, T. & Ruley, H. E. (1986). Adenovirus E1A coding sequences which enables ras and pmt oncogenes to transform cultured primary cells. Molecular and Cellular Biology 6, 887-899.
49. 243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter. Journal of Virology 69, 7402-7409.